Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
Clinical trial NCT05214001 · TERMINATED
Trial details
- NCT number
- NCT05214001
- Sponsor
- Messoud Ashina, MD
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-04-15
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.